Abraham CR, Razzaboni BL, Papastoitsis G, Picard E, Kanemaru K, Meckelein B, and Mucke L (1992) Purification and cloning of brain proteases capable of degrading theβ-amyloid precursor protein. Ann. N.Y. Acad. Sci. 674: 174–179.

Benedek G, Mucke L, Norita M, Albowitz B, and Creutzfeldt OD (1988) Anterior ectosylvian visual area (AEV) of the cat: physiological properties. Prog. Brain. Res. 75: 245–255.

Bloom FE, Campbell IL, and Mucke L (eds) (1993) Molecular and cellular mechanisms of neural-immune interactions. Discussions in Neuroscience, Vol. IX, Nos. 3+4. Elsevier Science Publishers, Amsterdam

Gan L and Mucke L (2008) Paths of convergence: Sirtuins in aging and neurodegeneration. Neuron 58:10–14.

Huang Y, Weisgraber KH, Mucke L, and Mahley RW (2003) Apolipoprotein E: Diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J. Mol. Neurosci. 23:189–204.

Lipton SA, Brenneman DE, Silverstein FS, Masliah E, and Mucke L (1995) Gp120 and neurotoxicity in vivo. Trends Pharmacol. Sci. 16: 122

Maciewicz R and Mucke L (1987) Principles of pain management. In Current Therapy in Neurological Disease-2. Bayless TM, Brain MC, Cherniack RM (eds). B.C. Decker, Inc., pp. 43–48

Maciewicz R and Mucke L (1987) Principles of pain management. In Current Therapy in Internal Medicine. Bayless TM, Brain MC, Cherniack RM (eds). B.C. Decker, Inc., pp. 1248–1253.

Masliah E, Ge N, and Mucke L (1996) Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10: 57–67.

Masliah E, Mallory M, Alford M, Ge N, and Mucke L (1995) Abnormal synaptic regeneration in hAPP695 transgenic and ApoE knockout mice. In Research Advances in Alzheimer’s Disease and Related Disorders. Iqbal K, Mortimer J, Winblad B, Wisniewski H (eds). John Wiley & Sons, pp. 405–414.

Masliah E, Ueda K, and Mucke L (1993) Pathophysiological basis of Alzheimer’s disease. In World Congress of Anatomic and Clinical Pathology. Santoscoy GG (ed). Moduzzi Editore, Bologna

Mucke L (1993) Transgenic models to study diseases of the nervous system: an in vivo approach to dissect complex pathogenetic networks. In Symposium in Immunology II. Eibl MM, Huber C, Peter HH, Wahn U (eds). Springer-Verlag, Berlin, pp. 121–31.

Mucke L, Abraham CR, and Masliah E (1996) Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann. N.Y. Acad. Sci. 777: 82–89.

Mucke L and Buttini M (1998) Molecular basis of HIV-associated neurologic disease. In Molecular Neurology. Martin J (ed).Scientific American Medicine, New York, pp. 135–154.

Mucke L, Buttini M, Mahley RW, Pitas RE, Raber J, and Wyss-Coray T (2000) Contributions of the glial injury response to the multifactorial pathogenesis of Alzheimer’s disease. In Neuro-Immune Interactions in Neurologic Disorders. Patterson P, Kordon C, Christen Y (eds). Springer-Verlag, Berlin, pp. 19–33.

Mucke L, Masliah E, and Campbell IL (1995) Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr. Top. Microbiol. Immunol. 202: 187–205.

Mucke L and Pitas R (2004) Food for thought: Essential fatty acid protects against neuronal deficits in transgenic mouse model of AD. Neuron 43: 596–599.

Raber J, LeFevour A, and Mucke L (2001) Androgen treatment reduces cognitive deficits in female apoE4 transgenic mice. In Alzheimer’s Disease: Advances in Etiology, Pathogenesis and Therapeutics. Iqbal K, Sisodia S, Winblad B (eds) John Wiley & Sons, Ltd., pp. 747–757.

Toggas SM and Mucke L (1996) Transgenic models in the study of AIDS dementia complex. Curr. Top. Microbiol. Immunol. 206: 223–241.

Toggas SM and Mucke L (1998) Transgenic models to assess the pathogenic potential of viral products in HIV-1-associated CNS disease. In The Neurology of AIDS. Gendelman HE, Lipton S, Swindells S (eds). Chapman & Hall, New York. pp. 156–167.

Wyss-Coray T and Mucke L (2002) Inflammation in neurodegenerative disease – A double-edged sword. Neuron 35: 419–432.

Wyss-Coray T and Mucke L (2000) Ibuprofen, inflammation and Alzheimer disease. Nat. Med. 6: 973–974.

Wyss-Coray T, Lin C, Von Euw D, Masliah E, Mucke L, and Lacombe P (2000) Alzheimer’s disease-like cerebrovascular pathology in transforming growth factor-β1 transgenic mice and functional metabolic correlates. Ann. N.Y. Acad. Sci. 903: 317–323.